Myriam Hakim outlines the progress that Japanese rare disease and oncology specialist Kyowa Kirin has made in the GCC region in recent years; the importance of the Saudi market to Kyowa Kirin and its customised strategy there; as well as the main game-changers for patients in the region, namely the creation of national rare disease policies, increased awareness, and the establishment of disease registries.
We have an important focus on the Saudi market and further expansion is planned from our side, strengthening our presence, expanding and growing the team while retaining and developing the talents in Saudi in a highly diverse and inclusive environment
